Copyright Reports & Markets. All rights reserved.

Global Hospital Acquired Pneumonia Drugs Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Hospital Acquired Pneumonia Drugs Market Overview

      • 1.1 Product Overview and Scope of Hospital Acquired Pneumonia Drugs
      • 1.2 Hospital Acquired Pneumonia Drugs Segment by Type
        • 1.2.1 Global Hospital Acquired Pneumonia Drugs Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 Phase II
        • 1.2.3 Early Phase (Phase I & II)
      • 1.3 Hospital Acquired Pneumonia Drugs Segment by Application
        • 1.3.1 Hospital Acquired Pneumonia Drugs Consumption Comparison by Application (2014-2025)
        • 1.3.2 Hospital Pharmacies
        • 1.3.3 Retail Pharmacies
        • 1.3.4 Drug Store
        • 1.3.5 E-Commerce
      • 1.4 Global Hospital Acquired Pneumonia Drugs Market by Region
        • 1.4.1 Global Hospital Acquired Pneumonia Drugs Market Size Region
        • 1.4.2 North America Status and Prospect (2014-2025)
        • 1.4.3 Europe Status and Prospect (2014-2025)
        • 1.4.4 China Status and Prospect (2014-2025)
        • 1.4.5 Japan Status and Prospect (2014-2025)
      • 1.5 Global Hospital Acquired Pneumonia Drugs Market Size
        • 1.5.1 Global Hospital Acquired Pneumonia Drugs Revenue (2014-2025)
        • 1.5.2 Global Hospital Acquired Pneumonia Drugs Production (2014-2025)

      2 Global Hospital Acquired Pneumonia Drugs Market Competition by Manufacturers

      • 2.1 Global Hospital Acquired Pneumonia Drugs Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Hospital Acquired Pneumonia Drugs Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Hospital Acquired Pneumonia Drugs Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Hospital Acquired Pneumonia Drugs Production Sites, Area Served, Product Types
      • 2.5 Hospital Acquired Pneumonia Drugs Market Competitive Situation and Trends
        • 2.5.1 Hospital Acquired Pneumonia Drugs Market Concentration Rate
        • 2.5.2 Hospital Acquired Pneumonia Drugs Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Hospital Acquired Pneumonia Drugs Production Market Share by Regions

      • 3.1 Global Hospital Acquired Pneumonia Drugs Production Market Share by Regions
      • 3.2 Global Hospital Acquired Pneumonia Drugs Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Hospital Acquired Pneumonia Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Hospital Acquired Pneumonia Drugs Production
        • 3.4.1 North America Hospital Acquired Pneumonia Drugs Production Growth Rate (2014-2019)
        • 3.4.2 North America Hospital Acquired Pneumonia Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Hospital Acquired Pneumonia Drugs Production
        • 3.5.1 Europe Hospital Acquired Pneumonia Drugs Production Growth Rate (2014-2019)
        • 3.5.2 Europe Hospital Acquired Pneumonia Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Hospital Acquired Pneumonia Drugs Production (2014-2019)
        • 3.6.1 China Hospital Acquired Pneumonia Drugs Production Growth Rate (2014-2019)
        • 3.6.2 China Hospital Acquired Pneumonia Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Hospital Acquired Pneumonia Drugs Production (2014-2019)
        • 3.7.1 Japan Hospital Acquired Pneumonia Drugs Production Growth Rate (2014-2019)
        • 3.7.2 Japan Hospital Acquired Pneumonia Drugs Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Hospital Acquired Pneumonia Drugs Consumption by Regions

      • 4.1 Global Hospital Acquired Pneumonia Drugs Consumption by Regions
      • 4.2 North America Hospital Acquired Pneumonia Drugs Consumption (2014-2019)
      • 4.3 Europe Hospital Acquired Pneumonia Drugs Consumption (2014-2019)
      • 4.4 China Hospital Acquired Pneumonia Drugs Consumption (2014-2019)
      • 4.5 Japan Hospital Acquired Pneumonia Drugs Consumption (2014-2019)

      5 Global Hospital Acquired Pneumonia Drugs Production, Revenue, Price Trend by Type

      • 5.1 Global Hospital Acquired Pneumonia Drugs Production Market Share by Type (2014-2019)
      • 5.2 Global Hospital Acquired Pneumonia Drugs Revenue Market Share by Type (2014-2019)
      • 5.3 Global Hospital Acquired Pneumonia Drugs Price by Type (2014-2019)
      • 5.4 Global Hospital Acquired Pneumonia Drugs Production Growth by Type (2014-2019)

      6 Global Hospital Acquired Pneumonia Drugs Market Analysis by Applications

      • 6.1 Global Hospital Acquired Pneumonia Drugs Consumption Market Share by Application (2014-2019)
      • 6.2 Global Hospital Acquired Pneumonia Drugs Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Hospital Acquired Pneumonia Drugs Business

      • 7.1 Basilea Pharmaceutica
        • 7.1.1 Basilea Pharmaceutica Hospital Acquired Pneumonia Drugs Production Sites and Area Served
        • 7.1.2 Hospital Acquired Pneumonia Drugs Product Introduction, Application and Specification
        • 7.1.3 Basilea Pharmaceutica Hospital Acquired Pneumonia Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Meiji Holdings
        • 7.2.1 Meiji Holdings Hospital Acquired Pneumonia Drugs Production Sites and Area Served
        • 7.2.2 Hospital Acquired Pneumonia Drugs Product Introduction, Application and Specification
        • 7.2.3 Meiji Holdings Hospital Acquired Pneumonia Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Cubist Pharmaceutical
        • 7.3.1 Cubist Pharmaceutical Hospital Acquired Pneumonia Drugs Production Sites and Area Served
        • 7.3.2 Hospital Acquired Pneumonia Drugs Product Introduction, Application and Specification
        • 7.3.3 Cubist Pharmaceutical Hospital Acquired Pneumonia Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Aridis Pharmaceutical
        • 7.4.1 Aridis Pharmaceutical Hospital Acquired Pneumonia Drugs Production Sites and Area Served
        • 7.4.2 Hospital Acquired Pneumonia Drugs Product Introduction, Application and Specification
        • 7.4.3 Aridis Pharmaceutical Hospital Acquired Pneumonia Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Valneva
        • 7.5.1 Valneva Hospital Acquired Pneumonia Drugs Production Sites and Area Served
        • 7.5.2 Hospital Acquired Pneumonia Drugs Product Introduction, Application and Specification
        • 7.5.3 Valneva Hospital Acquired Pneumonia Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 Bayer
        • 7.6.1 Bayer Hospital Acquired Pneumonia Drugs Production Sites and Area Served
        • 7.6.2 Hospital Acquired Pneumonia Drugs Product Introduction, Application and Specification
        • 7.6.3 Bayer Hospital Acquired Pneumonia Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 GlaxoSmithKline
        • 7.7.1 GlaxoSmithKline Hospital Acquired Pneumonia Drugs Production Sites and Area Served
        • 7.7.2 Hospital Acquired Pneumonia Drugs Product Introduction, Application and Specification
        • 7.7.3 GlaxoSmithKline Hospital Acquired Pneumonia Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 Merck
        • 7.8.1 Merck Hospital Acquired Pneumonia Drugs Production Sites and Area Served
        • 7.8.2 Hospital Acquired Pneumonia Drugs Product Introduction, Application and Specification
        • 7.8.3 Merck Hospital Acquired Pneumonia Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 Achaogen
        • 7.9.1 Achaogen Hospital Acquired Pneumonia Drugs Production Sites and Area Served
        • 7.9.2 Hospital Acquired Pneumonia Drugs Product Introduction, Application and Specification
        • 7.9.3 Achaogen Hospital Acquired Pneumonia Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served
      • 7.10 AstraZeneca
        • 7.10.1 AstraZeneca Hospital Acquired Pneumonia Drugs Production Sites and Area Served
        • 7.10.2 Hospital Acquired Pneumonia Drugs Product Introduction, Application and Specification
        • 7.10.3 AstraZeneca Hospital Acquired Pneumonia Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.10.4 Main Business and Markets Served

      8 Hospital Acquired Pneumonia Drugs Manufacturing Cost Analysis

      • 8.1 Hospital Acquired Pneumonia Drugs Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Hospital Acquired Pneumonia Drugs
      • 8.4 Hospital Acquired Pneumonia Drugs Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Hospital Acquired Pneumonia Drugs Distributors List
      • 9.3 Hospital Acquired Pneumonia Drugs Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Hospital Acquired Pneumonia Drugs Market Forecast

      • 11.1 Global Hospital Acquired Pneumonia Drugs Production, Revenue Forecast
        • 11.1.1 Global Hospital Acquired Pneumonia Drugs Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Hospital Acquired Pneumonia Drugs Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Hospital Acquired Pneumonia Drugs Price and Trend Forecast (2019-2025)
      • 11.2 Global Hospital Acquired Pneumonia Drugs Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Hospital Acquired Pneumonia Drugs Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Hospital Acquired Pneumonia Drugs Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Hospital Acquired Pneumonia Drugs Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Hospital Acquired Pneumonia Drugs Production, Revenue Forecast (2019-2025)
      • 11.3 Global Hospital Acquired Pneumonia Drugs Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Hospital Acquired Pneumonia Drugs Consumption Forecast (2019-2025)
        • 11.3.2 Europe Hospital Acquired Pneumonia Drugs Consumption Forecast (2019-2025)
        • 11.3.3 China Hospital Acquired Pneumonia Drugs Consumption Forecast (2019-2025)
        • 11.3.4 Japan Hospital Acquired Pneumonia Drugs Consumption Forecast (2019-2025)
      • 11.4 Global Hospital Acquired Pneumonia Drugs Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Hospital Acquired Pneumonia Drugs Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Hospital-acquired pneumonia (HAP) or nosocomial pneumonia refers to any pneumonia contracted by a patient in a hospital at least 48–72 hours after being admitted. It is thus distinguished from community-acquired pneumonia. It is usually caused by a bacterial infection, rather than a virus.

        The global Hospital Acquired Pneumonia Drugs market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Hospital Acquired Pneumonia Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Hospital Acquired Pneumonia Drugs market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        Basilea Pharmaceutica
        Meiji Holdings
        Cubist Pharmaceutical
        Aridis Pharmaceutical
        Valneva
        Bayer
        GlaxoSmithKline
        Merck
        Achaogen
        AstraZeneca

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        Phase II
        Early Phase (Phase I & II)

        Segment by Application
        Hospital Pharmacies
        Retail Pharmacies
        Drug Store
        E-Commerce

        Buy now